Who are Accurna's investors?

Accurna's investors include Fast Track Initiative,, UTokyo Innovation Platform.

Where is Accurna headquartered?

Accurna is headquartered in Tokyo, Japan.

What industry is Accurna in?

Accurna operates in Biotech, Healthcare.

Accurna

Pioneering drug delivery systems for nucleic acid therapeutics

Tokyo, Japan · Founded 2015

Biotech

Healthcare

Headquarters: Tokyo
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: accurna.com
Last Round: SeedDec 2015
Rounds: 1

About

AccuRna is a Japanese biotech startup founded in 2015 and headquartered in Tokyo, Japan, dedicated to the development of nucleic acid therapeutics with a focus on innovative drug delivery systems (DDS). The company pioneers unique DDS platforms capable of delivering both short-chain nucleic acids (ASO, siRNA, miRNA) and long-chain mRNA as therapeutic drugs. AccuRna's goal is to promote therapeutic innovation and provide effective treatments for refractory diseases with high unmet medical needs, leveraging nano micelle and other advanced delivery technologies to achieve safe and efficient nucleic acid medicine delivery.

Summary

Accurna is a Biotech company based in Tokyo, Japan, founded in 2015. Its most recent funding was a Seed round in Dec 2015. Investors include Fast Track Initiative, and UTokyo Innovation Platform.